Further study of chromosome 7p22 to identify the molecular basis of familial hyperaldosteronism type II

Journal of Human Hypertension

Volumn 25, Issue 9, 2011, Pages 560-564

  Carss, K J ^a   Stowasser, M ^b   Gordon, R D ^b   O'Shaughnessy, K M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

7p22; familial hyperaldosteronism type II; sequencing; sporadic primary aldosteronism; virtual karyotype

Indexed keywords

GENOMIC DNA;

ARTICLE; CHROMOSOME 7P; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA MICROARRAY; EIF 2A K1 GENE; FAMILIAL DISEASE; FAMILIAL HYPERALDOSTERONISM TYPE II; FOX 1 GENE; FSCN 1 GENE; GENE; GENE AMPLIFICATION; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENOTYPE; HUMAN; HYPERALDOSTERONISM; KARYOTYPE; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; RAC 1 GENE; RNF 216 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

CHROMOSOMES, HUMAN, PAIR 7; FORKHEAD TRANSCRIPTION FACTORS; GENOTYPE; HUMANS; HYPERALDOSTERONISM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80052031185     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.93     Document Type: Article

References (23)

1. Fogari R, Preti P, Zoppi A, Rinaldi A, Fogari E, Mugellini A. Prevalence of primary aldosteronism among unselected hypertensive patients: A prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test. Hypertens Res 2007; 30(2): 111-117.
2. Torpy DJ, Gordon RD, Lin JP, Huggard PR, Taymans SE, Stowasser M et al. Familial hyperaldosteronism type II: Description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab 1998; 83(9): 3214-3218.
3. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL, Krek AL. Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin Exp Pharmacol Physiol 1991; 18(5): 283-286.
4. Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P et al. A novel genetic locus for low renin hypertension: Familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 2000; 37(11): 831-835.
5. So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI et al. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens 2005; 23(8): 1477-1484.
6. Elphinstone MS, Gordon RD, So A, Jeske YW, Stratakis CA, Stowasser M. Genomic structure of the human gene for protein kinase A regulatory subunit R1-beta (PRKAR1B) on 7p22: No evidence for mutations in familial hyperaldosteronism type II in a large affected kindred. Clin Endocrinol (Oxf) 2004; 61(6): 716-723.
7. Jeske YW, So A, Kelemen L, Sukor N, Willys C, Bulmer B et al. Examination of chromosome 7p22 candidate genes RBaK, PMS2 and GNA12 in familial hyperaldosteronism type II. Clin Exp Pharmacol Physiol 2008; 35(4): 380-385.
8. Newton-Cheh C, Guo CY, Gona P, Larson MG, Benjamin EJ, Wang TJ et al. Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample. Hypertension 2007; 49(4): 846-856.
9. Huang JT, Lee V. Identification and characterization of a novel human FOXK1 gene in silico. Int J Oncol 2004; 25(3): 751-757.
10. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436(7050): 518-524.
11. Fearns C, Pan Q, Mathison JC, Chuang TH. Triad3A regulates ubiquitination and proteasomal degradation of RIP1 following disruption of Hsp90 binding. J Biol Chem 2006; 281(45): 34592-34600.
12. Lu L, Han AP, Chen JJ. Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses. Mol Cell Biol 2001; 21(23): 7971-7980.
13. Michaelson D, Abidi W, Guardavaccaro D, Zhou M, Ahearn I, Pagano M et al. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 2008; 181(3): 485-496.
14. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-386.
15. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, Nazareth L et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 2010; 362(13): 1181-1191.
16. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010; 42(1): 30-35.
17. Dreyer SD, Zhou G, Baldini A,Winterpacht A, Zabel B, Cole W et al. Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome. Nat Genet 1998; 19(1): 47-50.
18. Hall TA. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999; 41: 95-98.
19. International HapMap Consortium. The International HapMap Project. Nature 2003; 426(6968): 789-796.
20. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I et al. Human hypertension caused by mutations in WNK kinases. Science 2001; 293(5532): 1107-1112.
21. Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS et al. The human gene mutation database: 2008 update. Genome Med 2009; 1(1): 13.1-13.6.
22. Hoischen A, van Bon BW, Gilissen C, Arts P, van Lier B, Steehouwer M et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat Genet 2010; 42(6): 483-485.
23. Nikopoulos K, Gilissen C, Hoischen A, van Nouhuys CE, Boonstra FN, Blokland EA et al. Next-generation sequencing of a 40Mb linkage interval reveals TSPAN12 mutations in patients with familial exudative vitreoretinopathy. Am J Hum Genet 2010; 86(2): 240-247.